MedTrace Logo

Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics

NCT00255957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2006-04-19

No results posted yet for this study

Summary

The use of HES has been found clinically to improve patients with stroke if administered within a window period by means of hemodilution to improve rehology. We propose to see the effects of long term administraion of HES in the amounts required for treating stroke patients and study the effects on the kinetics of HES, its effects on coagulation and hemorheology.

Conditions

  • Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms

Interventions

DRUG

HES administration

DRUG

Hydroxy Ethyl Starch administration to stroke patients

Sponsors & Collaborators

  • Nizam's Institute of Medical Sciences University, India

    lead OTHER

Principal Investigators

  • Ramachandran Gopinath, MD,DA,FFARCSI · NIZAM'S INSTITUTE OF MEDICAL SCIENCES, PANJAGUTTA, HYDERABAD, INDIA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2006-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00255957 on ClinicalTrials.gov